Invo Bioscience Inc Reports Results For The Quarter Ended In June: Earnings Summary

INVO Fertility

15/08/2022 22:02

* INVO Bioscience Inc  INVO.OQ  reported a quarterly
adjusted loss
of 23 cents​​ per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 24
cents per share.
    * Revenue fell 29.8% to $146.00 thousand from a year ago;
analysts
expected $331.50 thousand. 
    * INVO Bioscience Inc's reported EPS for the quarter was a
loss
of 23 cents​.
    * The mean earnings estimate of analysts had risen by
about 4% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * INVO Bioscience Inc shares had risen by 67.2% this
quarter and
lost 67.9% so far this year.
    * The company reported a quarterly loss of $2.77 million.
    * Wall Street's median 12-month price target for INVO
Bioscience
Inc is $2.25 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 09:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.24          -0.23          Beat
 Mar. 31 2022      -0.25          -0.22          Beat
 Dec. 31 2021      -0.22          -0.01          Beat
 Sep. 30 2021      -0.20          -0.24          Missed